CLINICAL_TRIALS
trial_result
· 2011-08-04
Clinical Trial Update: R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 study of tipifarnib (R115777) in recurrent or metastatic non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED